- 11/25/22 - 5 forms, 1 itemgroup, 1 item, 1 language
Itemgroup: IG.elig

pht003568.v1.p1

1 itemgroup 4 items

pht003571.v1.p1

1 itemgroup 5 items

pht003569.v1.p1

1 itemgroup 5 items

pht003570.v1.p1

1 itemgroup 5 items
- 10/12/22 - 5 forms, 1 itemgroup, 2 items, 1 language
Itemgroup: pht002452
Principal Investigator: Mary V. Relling, PharmD, St. Jude Children's Research Hospital, Memphis, TN USA MeSH: Acute Lymphoblastic Leukemia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000426 Methotrexate plasma concentration is related to its clinical effects. To identify the genetic basis of interindividual variability in methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia (ALL), we performed a genome-wide analysis (GWAS) of 500,568 germline single-nucleotide polymorphisms (SNPs) in 434 children with ALL who received 3,014 courses of methotrexate at 2 to 5 g/m2. SNPs were validated in an independent cohort of 206 patients. Adjusting for age, race, sex, and methotrexate regimen, the most significant associations were with SNPs in the organic anion transporter polypeptide, *SLCO1B1* (rs11045879 (P = 1.7 x 10sup-10/sup) and rs4149081 (P = 1.7 x 10sup-9/sup) (Trevino et al, PMID: 19901119). To test whether rare variants in *SLCO1B1* could alter its function, we genotyped *SLCO1B1* exons in a slightly larger group of 699 children with ALL who received methotrexate and identified 93 single nucleotide polymorphisms (SNPs). We found several common and rare non-synonymous (NS) SNPs associated with methotrexate clearance. NS SNPs predicted to be functionally damaging (common or rare) were more likely to be found among patients with the lowest adjusted methotrexate clearance (lowest 10%) than patients with high clearance (highest 10%). Four *SLCO1B1* haplotypes were associated with reduced methotrexate clearance and we verified that these haplotypes have lower function with in vitro transport assays. We were able to quantitatively account for a third of the population variability in clearance of methotrexate with clinical and genetic covariates. This data set includes the dependent variable of methotrexate clearance and all of the SNP data available from arrays, sequencing, and genotyping.

Eligibility

1 itemgroup 4 items

pht002453.v1.p1

1 itemgroup 2 items

pht002454.v1.p1

1 itemgroup 3 items

pht002455.v1.p1

1 itemgroup 5 items
- 10/12/22 - 6 forms, 1 itemgroup, 5 items, 1 language
Itemgroup: pht002673

pht002675.v2.p1

1 itemgroup 6 items

pht003165.v1.p1

1 itemgroup 15 items

pht003171.v1.p1

1 itemgroup 2 items

pht002672.v2.p1

1 itemgroup 5 items

Eligibility

1 itemgroup 1 item

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial